Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

Open access
Kaczanowska, Sabina, Beury, Daniel W., Gopalan, Vishaka, Tycko, Arielle K., Qin, Haiying, Clements, Miranda E., Drake, Justin, Nwanze, Chiadika, Murgai, Meera, Rae, Zachary, Ju, Wei, Alexander, Katherine A., Kline, Jessica, Contreras, Cristina F., Wessel, Kristin M., Patel, Shil, Hannenhalli, Sridhar, Kelly, Michael C., Kaplan, Rosandra N.·2021·Cell

Abstract

Summary Metastasis is the leading cause of cancer-related deaths, yet we have limited knowledge of the metastatic microenvironment to effectively target this process. Microenvironmental changes occur at distant sites prior to clinically detectable metastatic disease; however, the key niche regulatory signals during metastatic progression remain poorly characterized. Here, we identify a core immune suppression gene signature in pre-metastatic niche formation that is expressed predominantly by myeloid cells. We target this immune suppression program by utilizing genetically engineered myeloid cells (GEMys) to deliver IL-12 to modulate the metastatic microenvironment. Our data demonstrate that IL12-GEMy treatment reverses immune suppression in the pre-metastatic niche by activating antigen presentation and T cell activation, resulting in reduced metastatic and primary tumor burden, and improved survival of tumor-bearing mice. We demonstrate that IL12-GEMys can functionally modulate the core program of immune suppression in the pre-metastatic niche to successfully rebalance the dysregulated metastatic microenvironment in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.02.048

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 203

Metadata

Authors
Kaczanowska, S., Beury, D. W., Gopalan, V., Tycko, A. K., Qin, H., Clements, M. E., Drake, J., Nwanze, C., Murgai, M., Rae, Z., Ju, W., Alexander, K. A., Kline, J., Contreras, C. F., Wessel, K. M., Patel, S., Hannenhalli, S., Kelly, M. C., & Kaplan, R. N.
Venue
Cell
Publisher
Elsevier BV
Published
2021-04
Volume
184
Issue
8
Pages
2033-2052.e21
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3136452579
Cited by
203
References
20
FWCI
11.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. https://app.cochat.ai/papers/10.1016/j.cell.2021.02.048
The paper
Kaczanowska, S., Beury, D. W., Gopalan, V., Tycko, A. K., Qin, H., Clements, M. E., Drake, J., Nwanze, C., Murgai, M., Rae, Z., Ju, W., Alexander, K. A., Kline, J., Contreras, C. F., Wessel, K. M., Patel, S., Hannenhalli, S., Kelly, M. C., & Kaplan, R. N. (2021). Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. https://doi.org/10.1016/j.cell.2021.02.048

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.